Sistemic announce ground breaking predictive diagnostic assay for protein production in a cell

Release Date: May 16, 2016


Glasgow, Scotland. Sistemic Ltd. today announced the launch of its first predictive diagnostic product for protein production utilising its novel miRNA technologies including SistemQC™, SistemSeek™ and SistemExpress™. The introduction of the first product in the new SistemCheck™ range will be for the prediction of indoleamine 2,3-dioxygenase (IDO) production in cells. 

Sistemic and Cynata announce cooperation on in-process purity assay development for Cell Therapy (CT) product.

Release Date: May 6, 2016


Glasgow, Scotland and Victoria, Australia.

Sistemic Ltd. and Cynata Therapeutics Limited (ASX:CYP) announced today that they have entered into an agreement which will see Sistemic use its novel SistemQC™ miRNA technology platforms, together with its extensive internal databases of cellular products to develop an in-process assessment assay for Cynata’s unique Cymerus™ Cell Therapy (CT) products.

Sistemic and RoosterBio Inc Announce broad Collaboration Agreement to Advance miRNA and Mesenchymal Stem/Stromal Cell (MSC) Regenerative Technology

Release Date: May 28, 2015


Frederick, MD, USA March 28, 2015 Sistemic Ltd. and RoosterBio Inc. announced today that they have entered into a commercial collaboration agreementand signed a memorandum of understanding whereby both companies will combine their technologies and work together towards advancing the field of mesenchymal stem/stromal cell (MSC) regenerative technology.